Invesco Biotechnology & Genome ETF
PBE
PBE
86 hedge funds and large institutions have $170M invested in Invesco Biotechnology & Genome ETF in 2015 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
0.26% less ownership
Funds ownership: 30.76% → 30.5% (-0.26%)
1% less funds holding
Funds holding: 87 → 86 (-1)
Holders
86
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$1.71M | |
| 2 | +$1.01M | |
| 3 | +$682K | |
| 4 |
QA
Quantitative Advantage
Minnetonka,
Minnesota
|
+$606K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$379K |
Top Sellers
| 1 | -$2.46M | |
| 2 | -$1.64M | |
| 3 | -$1.18M | |
| 4 |
Morgan Stanley
New York
|
-$992K |
| 5 |
CWM
Concert Wealth Management
San Jose,
California
|
-$929K |